|
Sign In to gain access to subscriptions and/or personal tools.
|
Acute Pulmonary Edema Due to Rosiglitazone Use in a Patient With Diabetes Mellitus
Nedim Çekmen, MD
73. Sok. 62/3, Emek, Ankara, Turkey; nedimcekmen{at}yahoo.com
Mustafa Cesur, MD
Riza Çetinba , MD
Pa a Bedel, MD
Özcan Erdemli, MD
Güven Hospital, Department of Anesthesiology and Intensive Care, Güven Hospital Department of Endocrinology, Kavaklidere, Ankara, Turkey
Rosiglitazone is a peroxisome proliferator active receptor. agonist, which increases insulin sensitivity in adipose tissue, muscle, and liver. Rosiglitazone is a member of the thiazolidinedione group, and because of its significantly positive effect on glycemic control, it is especially preferred in type 2 diabetic patients with a high cardiovascular disease risk. This drug, because of its decreasing effect on insulin resistance, is used alone or combined with type 2 diabetic drugs. A 73-year-old female patient was admitted to the emergency department with dyspnea, pink frothing phlegm, cyanosis, and tiredness. She was lethargic, uncooperative, and had no orientation. In arterial blood gases, hypoxemia and hypercapnia were found. She was taken to the general intensive care unit, and oxygen was applied via mask. The patient had a history of 10 years of diabetes mellitus, hypertension, and atherosclerotic cardiac disease, and she was using rosiglitazone for the past 6 weeks. Her chest x-ray was taken, and acute pulmonary edema was diagnosed. In her last echocardiography, which was performed 1 year before, no signs indicating cardiac failure and pleural effusion could be found. Therefore, it was concluded that pulmonary edema occurred as a complication of rosiglitazone use. After stabilizing the patient's vital signs, blood glucose levels, and lactate levels, medical treatment of diabetes mellitus was rearranged, and she was discharged on the seventh day after her admittance. In a patient with diabetes mellitus who has been admitted to the intensive care unit because of acute pulmonary edema, for differential diagnosis, use of rosiglitazone should be kept in mind during the determination of treatment. Therefore, the authors aim to discuss the effect of rosiglitazone on creating acute pulmonary edema with a case report presentation.
Key Words: rosiglitazone acute pulmonary edema type 2 diabetes mellitus intensive care unit
References
- Balfour JA, Plosker GL. Rosiglitazone. Drugs. 1999;57:921-930.[CrossRef][Medline]
[Order article via Infotrieve]
- Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation. 2003;108:2941-2948.[Free Full Text]
- Einhorn D, Aroda VR, Henry RR. Glitazones and the management of insulin resistance. Endocrinol Metab Clin North Am.2004;33:595-616.[CrossRef][Medline]
[Order article via Infotrieve]
- Wang F, Aleksunes LM, Reagan LA, et al. Management of rosiglitazone-induced edema: two case reports and a review of the literature. Diabetes Technol Ther. 2002;4:505-514.[CrossRef][Medline]
[Order article via Infotrieve]
- Niemeyer NV, Janney LM. Thiazolidinedione-induced edema. Pharmacotherapy. 2002;22:924-929.[CrossRef][Medline]
[Order article via Infotrieve]
- Bell DS. Unilateral edema due to a thiazolidinedione. Diabetes Care. 2003;26:2700-2700.[Free Full Text]
- Kermani A, Garg A. Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo Clin Proc. 2003;78:1088-1091.[Abstract/Free Full Text]
- Idris L, Gray S, Donnelly R. Rosiglitazone and pulmonary edema: an acute dose-dependent effect on human endothelial cell permeability. Diabetologia. 2003;46:288-290.[Medline]
[Order article via Infotrieve]
- Mudaliar S, Chang AR, Henry RR. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract. 2003;9:406-416.[Medline]
[Order article via Infotrieve]
- Cheng AY, Fantus IG. Thiazolidinedione-induced congestive heart failure. Ann Pharmacother. 2004;38:817-820.[Abstract/Free Full Text]
- Fonseca V, Rosenstock J, Patwardhan R, et al. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. JAMA. 2000;283:1695-1702.[Abstract/Free Full Text]
- Del Prato S, Volpe L. Rosiglitazone plus metformin: combination therapy for type 2 diabetes. Expert Opin Pharmacother. 2004;5:1411-1414.[CrossRef][Medline]
[Order article via Infotrieve]
- Singh N. Rosiglitazone and heart failure: long-term vigilance. J Cardiovasc Pharmacol Ther. 2004;9:21-25.[Abstract/Free Full Text]
- Wang CH, Weisel RD, Liu PP, Fedak PW, Verma S. Glitazones and heart failure: critical appraisal for the clinician. Circulation. 2003;107:1350-1354.[Free Full Text]
Journal of Intensive Care Medicine, Vol. 21, No. 1,
47-50 (2006)
DOI: 10.1177/0885066605283385

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|